Recent advances in depression research: From stress to molecular biology and brain imaging

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 5, 1997, Pages 3-6

  Risch, S Craig ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; DEPRESSION; GENETIC SUSCEPTIBILITY; IMAGING SYSTEM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS;

ADOLESCENT; ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CARRIER PROTEINS; CHILD; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE CHANGE EVENTS; MAGNETIC RESONANCE IMAGING; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, GENETIC; NERVE TISSUE PROTEINS; RECEPTORS, SEROTONIN; RESEARCH; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030907571     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:911-1028
2. Berretini W, Ferraro TN, Goldin LR, et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci U S A 1994;91:5918-5921
3. Brunner HG, Nelen M, Breakfield XO, et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993;262:578-580
4. Nielsen DA, Goldman D, Virkkunen M, et al. Suicidality and 5-hydroxy-indoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 1994;51:34-38
5. Rosenblum LA, Coplan SD, Friedman S, et al. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry 1994;35:221-227
6. Tennant C, Bebbington P, Hurry J. The role of life events in depressive illness: is there substantial causal relation? Psychol Med 1981;11:379-389
7. Paykel ES. Life events, social support and depression. Acta Psychiatr Scand Suppl 1994;377:50-58
8. Cui X, Vaillant GE. Antecedents and consequences of negative life events in adulthood: a longitudinal study. Am J Psychiatry 1996;153(11):21-26
9. Singer MI, Anglin TM, Song LY, et al. Adolescents exposure to violence and associated symptoms of psychological trauma. JAMA 1995;273: 477-482
10. Kendler KS, Kessler RC, Walters EE, et al. Stressful life events genetic liability and onset of an episode of major depression in women. Am J Psychiatry 1995;152:833-842
11. Risch SC, Nemeroff CB. Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry 1992;53(10, suppl):3-7
12. Perry EK, Marshall EF, Blessed G, et al. Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 1983;142: 188-192
13. Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982;216:1337-1339
14. Briley MS, Langer SZ, Raisman R, et al. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 1980; 209:303-305
15. Paul SM, Rehavi M, Skolnick P, et al. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin 'transporter.' Arch Gen Psychiatry 1981;38:1315-1317
16. Nemeroff CB, Knight DL, Krishnan KRR, et al. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Arch Gen Psychiatry 1988;45:919-923
17. Pletscher A. Platelets as models: use and limitations. Experientia 1988;44: 152-155
18. Da Prada M, Cesura AM, Launay JN, et al. Platelets as a model for neurones? Experientia 1988;44:115-126
19. Pandey BN, Pandy SC, Janicak PG, et al. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 1990;28:215-222
20. de Montigny C, Aghajanian GK. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978;202:1303-1306
21. de Montigny C. Electroconvulsive treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther 1984;228:230-234
22. de Montigny C, Chaput Y, Blier P. Lithium augmentation of antidepressant treatment: an evidence for the involvement of the 5-HT system? In: Briley M, ed. New Concepts in Depression. London, England: Macmillan; 1987: 144-159
23. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987;7:24S-35S
24. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-226
25. Lopez JF, Chalmers DT, Vasquez DM, et al. Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 1994; 35:287-290
26. Panel. Beyond cell membrane receptors: the role of transcription factors and gene expressions as factors in the therapeutic actions of antidepressants and antipsychotic drugs. In: Abstracts of the 34th Annual Meeting of the American College of Neuropsychopharmacology; December 1995:46-48; San Juan, Puerto Rico
27. George MS, Retter TA, Kimbrell TA, et al. Brain imaging in mania. In: Goodnick P, ed. Mania. Washington, DC: APA Press. In press
28. George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry 1993;54(11, suppl):6-13
29. George MS, Ketter TA, Parekh PI, et al. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 1995;152:341-351
30. Drevets WC, Videen TO, Preskom SH, et al. A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628-3641
31. Mayberg H, Brannan SK, Mahurin RK, et al. The emerging role of the anterior cingulate in the regulation of mood with PET studies in depressed patients and normal sadness. In: Abstracts of the 34th Annual Meeting of the American College of Neuropsychopharmacology; December 1995:65; San Juan, Puerto Rico